Effect of Chitrakadi Churna & Mishyadi Churna in the Management of Kasa in Children

A Comparative Clinical Study on the Efficacy of Chitrakadi Churna & Mishyadi Churna in the Management of Kasa in Children - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/02/080925

Enrollment

100

Registered

2025-02-19

Start date

Unknown

Completion date

Unknown

Last updated

2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J069- Acute upper respiratory infection,unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1 The patients having classical symptomatology of Kasa Roga. 2 The patient under 16 years of age irrespective of caste, religion, sex, habits, socioeconomic status & those who fulfill the diagnosis will be selected for the study. 3 Children will be diagnosed on the basis of following symptoms of Kasa mentioned in classical texts, in addition to the signs and symptoms mentioned in contemporary texts. Kasa severity Shira shoola Aruchi Swarbheda Shukpurna Gala Aashyata

Exclusion criteria

Exclusion criteria: 1. Patients above 16 years of age. 2. Acute Patients with infection will be excluded. 3. Patient suffering from Kshtaja and Kshayaja Kasa. 4. Patient suffering with any chronic disorder as Pneumonia, COPD (Chronic Obstructive Pulmonary Disorder), Emphysema, Bronchiectasis.

Design outcomes

Primary

Measure	Time frame
The effect of Chitrakadi Churna & Mishyadi Churna in the Management of Kasa in ChildrenTimepoint: Base Line (Visit 1 ) to end of treatment.	—

Secondary

Measure	Time frame
the efficacy of Chitrakadi Churna in management of kasa roga, Shirashoola, Swarabheda, Aruchi, Shukapurnagalaasyata, CBC & absolute eosinophil count. the efficacy of Mishyadi Churna in management of kasa roga, Shirashoola, Swarabheda, Aruchi, Shukapurnagalaasyata, CBC & absolute eosinophil count.Timepoint: Base Line (visit 1) to end of treatement.	—

Countries

India

Contacts

Public ContactDr Arun Mishra

Mandsaur Institute of Ayurveda Education & Research

arunmisra2007@gmail.com8839664965

Outcome results